Evidence map›Paper›PMID 40497950›Full record

ArticleCells2025

Dynamic Expression and Functional Implications of the Cell Polarity Gene, Dchs1, During Cardiac Development.

Kathryn Byerly, Cayla Wolfe, Hannah Parris, Charlotte Griggs, Emily Wilson, Matthew Huff, Molly Griggs, Jordan Morningstar, Lilong Guo, Fulei Tang and 6 more

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Mechanisms of mitral valve development and disease.Frontiers in cardiovascular medicine · 2026
    Review
  4. Recent advances in omics-based research of mitral valve disease.Frontiers in cardiovascular medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kathryn ByerlyDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Cayla WolfeDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Hannah ParrisDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Charlotte GriggsDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Emily WilsonDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Matthew HuffDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Molly GriggsDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0009-0003-7786-5053
Jordan MorningstarDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Lilong GuoDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0001-9376-3274
Fulei TangDepartment of Comparative Medicine, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0003-2102-1137
Jan GuzDepartment of Comparative Medicine, Medical University of South Carolina, Charleston, SC 29407, USA.
Taylor PetrucciDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0003-1524-5804
Ranan PhookanDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0009-0005-0625-2449
Brian LoizziDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.
Cortney GensemerDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.ORCID 0000-0002-8492-3536
Russell A NorrisDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29407, USA.

Funding

Mechanism of Myocardial Fibrosis Induced by Mitral Valve ProlapseR01HL173930 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI JUDY W HUNG, Serguei MELNITCHOUK · 2024 to 2026
$5.4M
Cilia and Valvular Heart DiseaseR01HL131546 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI NORRIS, RUSSELL · 2016 to 2025
$4.4M
Dzip1 and Mitral Valve ProlapseR01HL149696 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI NORRIS, RUSSELL · 2020 to 2023
$2.0M
NHLBI NIH HHS R01 HL131546NHLBI NIH HHS R01 HL149696NHLBI NIH HHS R01 HL173930NIH, AHA HL131546, HL149696, AHA:24TPA1304545
6 · The paper itself

Abstract

Intercellular interactions among cardiac cell populations are essential for cardiac morphogenesis, yet the molecular mechanisms orchestrating these events remain incompletely understood. Dachsous1 (Dchs1), an atypical cadherin linked to mitral valve prolapse, is a core planar cell polarity protein whose function in the developing heart has not been fully elucidated. To address this, we generated a Dchs1-HA knock-in mouse model to define its spatial, temporal, and cellular expression patterns. Using immunohistochemistry, western blotting, and single-cell transcriptomics across developmental stages, we demonstrate that cardiac Dchs1 expression is restricted to non-cardiomyocyte lineages. DCHS1 displays dynamic subcellular localization and tissue organization depending on the developmental timepoint, with staining being found in epicardial and endocardial surfaces at earlier embryonic stages and in the compact myocardium in later fetal and neonatal stages. During fetal and neonatal stages, DCHS1-positive non-myocyte, non-endothelial cells form polarized extensions that bridge endothelial and non-myocyte, non-endothelial cells, suggesting direct heterotypic and homotypic interactions. Western blotting revealed evidence of DCHS1 proteolytic cleavage, with intracellular C-terminal fragments. RNA co-expression with its binding partner FAT4 supports a conserved, non-myocyte-specific DCHS1-FAT4 signaling axis. These findings identify DCHS1 as a potential molecular tether that is utilized in intercellular communications during cardiac development, with implications for congenital and acquired heart disease.

Indexed as

CadherinsCell PolarityGene Expression Regulation, DevelopmentalHeartOrganogenesisAnimalsMiceMyocardiumCadherinsFat4 protein, mousecadherincardiac developmentcell polarityDachsous

Identifiers

PMID40497950
PMCPMC12153708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.